SNSE/AMGN (SNSE/AMGN)

Santiago Stock Exchange: SNSE/AMGN · USD

$445

+19.69 (+4.6%)· Recorded snapshot

Market cap	238.8T
Revenue (ttm)	35.1T
Net income (ttm)	8.1T
EPS (ttm)	$15,870
P/E (trailing)	27.6x
P/E (forward)	18.9x
Dividend	$9,340 (2.13%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 35.1T
Net income (ttm): 8.1T
EPS (ttm): $15,870
P/E (trailing): 27.6x
P/E (forward): 18.9x
Market cap: 238.8T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.9

P25 n/aP50 n/aP75 n/a

Trailing P/E27.6

P25 n/aP50 n/aP75 n/a

ROE91.5

P25 n/aP50 n/aP75 n/a

ROIC19.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SNSE/AMGN indicators

Market & fundamental data

Available fields

243

Groups with data

Currency

USD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-11-03
Employees	31,500
Employees change	3,500
Employees growth	12.5%
Enterprise value	$281.3T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1980
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US0311621009
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Market cap	$238.8T
Next earnings date	2026-11-03
Price	$444.63
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	snse/AMGN
Website	https://www.amgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	25.24x
Average P/E ratio (3Y)	29.44x
Average P/E ratio (5Y)	25.49x
Earnings yield	3.63%
EV/Earnings	34.81x
EV/EBIT	22.44x
EV/EBITDA	16.29x
EV/FCF	29.91x
EV/Sales	7.49x
FCF / EV yield	3.34%
FCF yield	3.94%
Forward P/E	18.88x
Graham number	82.58562
Graham upside	-81.43%
Lynch fair value	$131.87
Lynch upside	-70.34%
P/(FCF - SBC) ratio	26.66x
P/(OCF - SBC) ratio	21.54x
P/B ratio	22.09x
P/E ratio	27.57x
P/FCF ratio	25.37x
P/OCF ratio	20.69x
P/S ratio	6.78x
Price/EBITDA ratio	14.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.4%
EBITDA margin	45.33%
Effective tax rate	15.01%
FCF margin	24.96%
Gross margin	71.89%
Operating margin	33.4%
Pretax margin	27%
Profit margin	22.95%
Profit per employee	$255.7M
Profitable quarters	9
Profitable years	23
Revenue per employee	$1.1B
ROA	8.67%
ROA (5Y)	8.22%
ROCE	18.14%
ROE	91.47%
ROE (5Y)	101.82%
ROIC	19.76%
ROIC (5Y)	20.52%
SBC / revenue	1.29%
Tax / revenue	4.05%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	31.6%
EPS growth (Q)	64.91%
EPS growth (QoQ)	30.84%
EPS growth 10Y	5.12%
EPS growth 3Y	2.72%
EPS growth 5Y	10.3%
EPS growth quarters	6
EPS growth years	1
FCF growth	-4.06%
FCF growth (Q)	82.58%
FCF growth (QoQ)	136.22%
FCF growth 3Y	1.66%
FCF growth 5Y	2.72%
Gross profit growth	13.09%
Gross profit growth (Q)	12.23%
Gross profit growth 3Y	11.58%
Gross profit growth 5Y	7.36%
Net income growth	32.09%
Net income growth (Q)	65.85%
Net income growth (QoQ)	30.57%
Net income growth 3Y	3.09%
Net income growth 5Y	8.76%
Net income growth quarters	6
Net income growth years	1
OCF growth	3.87%
OCF growth (Q)	75.53%
OCF growth (QoQ)	82.82%
OCF growth 10Y	2.7%
OCF growth 3Y	4.93%
OCF growth 5Y	5.48%
Operating income growth	19.55%
Operating income growth (Q)	19.33%
Operating income growth 3Y	8.67%
Operating income growth 5Y	6.56%
Revenue growth	9.1%
Revenue growth (Q)	9.53%
Revenue growth (QoQ)	16.66%
Revenue growth 10Y	5.42%
Revenue growth 3Y	12.74%
Revenue growth 5Y	8.37%
Revenue growth quarters	13
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-2.1T
Depreciation and amortization	$4.5T
EBIT	$11.7T
EBITDA	$15.9T
EPS	$15,870.00
Financing cash flow	$-3.8T
Free cash flow	$9.4T
Free cash flow minus SBC	$8.9T
Gross profit	$25.2T
Income taxes	$1.4T
Investing cash flow	$-2.2T
Net borrowing	$1.3T
Net cash flow	$5.5T
Net income	$8.1T
Operating cash flow minus SBC	$11T
Operating income	$11.7T
Revenue	$35.1T
Stock-based compensation	$453.3B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.89
Book value per share	$19,918.89
Debt / EBITDA	3.27
Debt / equity	4.9
Debt / FCF	5.63
Goodwill	$18.4T
Interest coverage	4.14
Long-term assets	$53.6T
Long-term liabilities	$52.2T
Net cash (debt)	$-39.9T
Net cash / market cap	-16.78%
Net debt / EBITDA	2.51
Net debt / equity	3.71
Net debt / FCF	4.26
Piotroski F-Score	8
Property, plant and equipment	$8.4T
Shareholders' equity	$10.8T
Tangible book value	$-25.3T
Tangible book value per share	$-46,809.74
Total assets	$88.1T
Total cash	$12.9T
Total debt	$52.8T
Total liabilities	$77.3T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.42
Current assets	$34.5T
Current liabilities	$25.1T
Current ratio	1.37
Inventory turnover	1.67
Net working capital	$843B
Quick ratio	0.95
Working capital	$8.7T
Working capital turnover	4,466.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.46%
Dividend growth	5.86%
Dividend growth (10Y)	10.12%
Dividend growth (3Y)	6.07%
Dividend growth (5Y)	7.64%
Dividend growth years	12
Dividend payment date	2026-09-11
Dividend payment years	14
Dividend payout frequency	Quarterly
Dividend per share	$9,340.25
Dividend yield	2.14%
Ex-dividend date	2026-08-21
Last dividend	$2.52
Payout ratio	60.45%
Shareholder yield	1.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	157.88%
10Y return CAGR	13.43%
10Y total return	252.4%
150-day SMA	$366.68
1D price change	4.63%
1M price change	13.09%
1M total return	13.09%
1W price change	7.7%
1W total return	7.7%
1Y price change	74.26%
1Y return CAGR	79.74%
1Y total return	79.67%
20-day SMA	$416.31
200-day SMA	$358.20
3M price change	22.09%
3M total return	22.83%
3Y price change	74.26%
3Y return CAGR	24.51%
3Y total return	93.07%
50-day SMA	$415.62
50-day SMA vs 200-day SMA	50over200
52-week high	$444.63
52-week high date	2026-10-27
52-week low	$255.16
52-week low date	2025-12-22
5Y price change	74.26%
5Y return CAGR	15.5%
5Y total return	105.54%
6M price change	33.61%
6M total return	35.44%
All-time high	$444.63
All-time high date	2026-10-27
All-time low	$152.89
All-time low date	2015-06-30
Average true range (ATR)	$3.92
Average volume	0
Change from 52-week high	0%
Change from 52-week low	74.26%
Change from all-time high	0%
Change from all-time low	190.82%
Monthly RSI	86.79
Previous close	$424.94
Price vs 150-day SMA	21.26%
Price vs 20-day SMA	6.8%
Price vs 200-day SMA	24.13%
Price vs 50-day SMA	6.98%
Relative volume	1,000
RSI	79.02
Sharpe ratio	1.63
Sharpe ratio (3Y)	0.92
Sharpe ratio (5Y)	0.69
Sortino ratio	5.16
Sortino ratio (3Y)	3.31
Sortino ratio (5Y)	2.79
Weekly RSI	71.39
YTD price change	33.61%
YTD total return	36.48%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	539.2M
Shares change (QoQ)	0%
Shares change (YoY)	0.46%
Shares held by insiders	0.17%
Shares held by institutions	83.82%
Short ratio	4.8 days

Deeper analysis on SNSE/AMGN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SNSE/AMGN report

Is a complete SNSE/AMGN research report available?

No complete published report is available for snse/AMGN (SNSE/AMGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SNSE/AMGN (SNSE/AMGN)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/AMGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/AMGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/AMGN

Frequently asked questions